Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidoglycan (also called murein) is a unique and essential component of bacterial cell walls that provides structural integrity and protection. It is a heteropolymer composed of alternating amino sugar units, N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc), forming a carbohydrate backbone. Each MurNAc unit is attached to a short peptide chain (typically 4-5 amino acids) containing L- and D-amino acids. The specific peptide composition varies between bacterial species; for example, Gram-negative bacteria often have L-alanine, D-glutamic acid, meso-diaminopimelic acid, and D-alanine, while Gram-positive bacteria frequently contain L-alanine, D-glutamine, L-lysine, and D-alanine, often with an interbridge. These peptide chains cross-link the glycan strands, creating a strong, mesh-like lattice structure. The thickness of the peptidoglycan layer differs significantly between bacterial types: Gram-positive bacteria have a thick layer (up to 40 layers, ~20% of cell wall dry weight), whereas Gram-negative bacteria have a much thinner layer (~10% of cell wall dry weight) located between the inner and outer membranes. Peptidoglycan is absent in human cells, making its biosynthesis a prime target for antibiotics.
Inhibition of biosynthesis or degradation, leading to bacterial cell lysis. Antibiotics like penicillins inhibit the cross-linking of peptidoglycan chains.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidoglycan.